Stem Cells Spin S.A.

zł 0.49As of Sun 8 Nov 2026, 12:00 UTC
WSE:SCSHealthcare
Country Poland
PE (Fwd) •••
TSR 10Y CAGR (11.14%)
Div yield —
ROE (9.30%)
Biotechnology
Beta (5Y) 0.14
PE TTM —
TSR TTM 23.74%
Mkt cap zł 20.25M
ROIC (9.31%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
zł 0.564
15.18%
(47.22%)
Hold 10|11|10|11|12
4Q25
1Q26
2Q26
3Q26
Earnings per sharezł
0.01
0.01
0.01
0.01
27.44%
23.54%
25.16%
20.30%
Revenuezł M
2.024
2.066
2.027
2.137
9.60%
10.49%
7.41%
11.70%
Peers (US$5.115M)
Cap (US$)
PE
14.53M
112.3x
7.876M
—
3.756M
—
Capital
TTM
5Y
10Y
Leveragex
3.699
1.103
0.727
EBIT/Intx
0.361
0.093
0.097
Own earn%
7.72
(8.51)
(2.85)
Sh yield%
13.32
62.74
61.72
Owners
Insiders/Inst%
3.74
22.58
Short interest%
2.44
SBC / revenue%
1.98
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
25–30
$1 testx
0.5
Incr. ROIC%
1